Hi Bruce,
I think we will see a lot of AD drug development news in the media now, think of it as a blessing!
Did you read the article posted by Davisite? That is a good one.
I don’t think that the stage of Xanamem development or potential indications for the drug have been factored into the SP at all really.
Watch this Space lol.
GLTAH
Under valued stock, page-166
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $70.50M | |||
| Open | High | Low | Value | Volume |
| 2.6¢ | 2.8¢ | 2.6¢ | $324.6K | 12.16M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 7020618 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 372676 | 2 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| ACW (ASX) Chart |